Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Infections and Infectious Diseases | Gastroenterology | Family Medicine

Intra-Abdominal Infections Clinical Trials

A listing of Intra-Abdominal Infections medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

Alabama

Research Site
Huntsville Alabama 35801
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

View More »

Call for Information (Investigational Site 0008)
Huntsville Alabama 35801
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

California

Research Site
Orange California 92868
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

View More »

Call for Information (Investigational Site 0109)
Orange California 92868
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Maryland

Research Site
Baltimore Maryland 21201
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

View More »

Call for Information (Investigational Site 0113)
Baltimore Maryland 21201
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Michigan

Research Site
Royal Oak Michigan 48073
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

View More »

Call for Information (Investigational Site 0006)
Royal Oak Michigan 48073
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Minnesota

Research Site
Minneapolis Minnesota 55422
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

View More »

Call for Information (Investigational Site 0005)
Minneapolis Minnesota 55422
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

New Jersey

Research Site
Somers Point New Jersey 08244
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

View More »

Call for Information (Investigational Site 0004)
Somers Point New Jersey 08244
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Pennsylvania

Research Site
Philadelphia Pennsylvania 19102
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

View More »

Call for Information (Investigational Site 0112)
Philadelphia Pennsylvania 19102
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Argentina

Research Site
Buenos Aires International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Bulgaria

Research Site
Sofia International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Chile

Research Site
Santiago International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Colombia

Research Site
Bogota International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Estonia

Research Site
Tallinn International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Germany

Research Site
Haar International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Greece

Research Site
Alimos International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Korea

Research Site
Seoul International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Latvia

Research Site
Riga International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Lithuania

Research Site
Vilnius International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Mexico

Research Site
Mexico City International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Peru

Research Site
Lima International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Poland

Research Site
Warsaw International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Portugal

Research Site
Paco D'arcos International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Romania

Research Site
Bucharest International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Russia

Research Site
Moscow International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

South Africa

Research Site
Midrand International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Spain

Research Site
Madrid International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Ukraine

Research Site
Kiev International
New

A clinical research study to treat complicated Intra-Abdominal Infection (cIAI) in patients 18 years and older.

Argentina

Merck Sharp & Dohme (Argentina) Inc.
Buenos Aires
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Bulgaria

Merck Sharp & Dohme Bulgaria EOOD
Sofia
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Chile

Merck Sharp & Dohme (I.A.) Corp.
Santiago
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Colombia

MDS Colombia SAS
Bogota
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Estonia

Merck Sharp & Dohme OU
Tallinn
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Germany

Merck Sharp & Dohme GmbH
Haar
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Greece

Vianex, S.A. / MSD
Alimos
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Korea, Republic of

MSD Korea LTD
Seoul
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Latvia

Merck Sharp & Dohme Latvija SIA
Riga
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Lithuania

UAB Merck Sharp & Dohme
Vilnius
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Mexico

MSD
Mexico City
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Peru

Merck Sharp & Dohme, Peru S.R.L.
Lima
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Poland

MSD Polska Sp. Z o.o.
Warsaw
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Portugal

Merck Sharp & Dohme Lda.
Paco D'arcos
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Romania

Merck Sharp & Dohme Romania SRL
Bucharest
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

Russian Federation

Merck Sharp & Dohme IDEA, Inc.
Moscow
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

South Africa

MSD (Pty) LTD South Africa
Midrand
Updated

A clinical research study of MK-7655 250 mg with imipenem/cilastatin, MK-7655 125 mg with imipenem/cilastatin, imipenem/cilastatin with placebo and Matching placebo to MK-7655 for the treatment of Intra-abdominal Infections

First 1 2 Last